Predictions
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€5.50
20.02.22
20.02.22
-
20.02.23
20.02.23
-9.86%
05.03.22
05.03.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.02
16.02.22
16.02.22
-
16.02.23
16.02.23
-10.26%
19.02.22
19.02.22
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.86
28.01.22
28.01.22
€7.20
28.01.23
28.01.23
-32.31%
29.01.23
29.01.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.52
23.01.22
23.01.22
-
23.01.23
23.01.23
7.06%
06.02.22
06.02.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.30
23.01.22
23.01.22
-
23.01.23
23.01.23
15.82%
06.02.22
06.02.22
Risky Investment
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.98
23.01.22
23.01.22
-
23.01.23
23.01.23
8.80%
06.02.22
06.02.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.62
14.01.22
14.01.22
-
14.01.23
14.01.23
-12.67%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.41
05.12.21
05.12.21
€3.00
05.12.22
05.12.22
-0.78%
21.07.22
21.07.22
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.96
01.12.21
01.12.21
€6.00
01.12.22
01.12.22
-2.70%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.91
01.12.21
01.12.21
-
01.12.22
01.12.22
-1.46%
11.12.21
11.12.21
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.25
30.11.21
30.11.21
-
30.11.22
30.11.22
-17.83%
12.12.21
12.12.21
Probably not worthwhile Investment
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.22
29.11.21
29.11.21
-
29.11.22
29.11.22
-16.11%
12.12.21
12.12.21
Could be worthwhile Investment >10% per year
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.40
29.11.21
29.11.21
-
29.11.22
29.11.22
45.45%
10.08.22
10.08.22
Could be worthwhile Investment >10% per year
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.45
29.11.21
29.11.21
-
29.11.22
29.11.22
-50.07%
06.12.21
06.12.21
Risky Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.00
28.11.21
28.11.21
-
28.11.22
28.11.22
7.65%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.50
22.11.21
22.11.21
-
22.11.22
22.11.22
-2.83%
28.11.21
28.11.21
Risky Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.37
22.11.21
22.11.21
-
22.11.22
22.11.22
-20.45%
27.11.21
27.11.21
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€40.00
20.11.21
20.11.21
-
20.11.22
20.11.22
-52.74%
11.05.22
11.05.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€7.40
19.11.21
19.11.21
-
19.11.25
19.11.25
1.84%
29.11.21
29.11.21
Growpros Cannabis Ventures Inc
Start price
Target price
Perf. (%)
€0.13
19.11.21
19.11.21
-
19.11.25
19.11.25
2.54%
22.11.21
22.11.21
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€46.25
17.11.21
17.11.21
€37.50
30.11.22
30.11.22
-19.46%
18.11.21
18.11.21
Could be very worthwhile Investment >20% year
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€37.75
17.11.21
17.11.21
€50.00
17.11.22
17.11.22
4.64%
27.11.21
27.11.21
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.97
15.11.21
15.11.21
-
15.11.22
15.11.22
-28.16%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year